VRDN - Viridian Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRDN is currently covered by 13 analysts with an average price target of $32.04. This is a potential upside of $18.54 (137.33%) from yesterday's end of day stock price of $13.5.

Viridian Therapeutics's activity chart (see below) currently has 26 price targets and 89 ratings on display. The stock rating distribution of VRDN is 94.2% BUY and 5.8% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 15.15% with an average time for these price targets to be met of 108.88 days.

Highest price target for VRDN is $61, Lowest price target is $22, average price target is $38.33.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 23-Apr-2025. First documented stock forecast 20-Jan-2021.

Currently out of the existing stock ratings of VRDN, 65 are a BUY (94.2%), 4 are a HOLD (5.8%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$34

$20.5 (151.85%)

$34

3 days ago
(23-Apr-2025)

1/15 (6.67%)

$20.49 (151.67%)

40

Buy

$38

$24.5 (181.48%)

$38

3 months 19 days ago
(07-Jan-2025)

0/14 (0%)

$17.09 (81.73%)

Hold

$27

$13.5 (100.00%)

$37

4 months 7 days ago
(19-Dec-2024)

0/2 (0%)

$8.27 (44.15%)

Buy

$47

$33.5 (248.15%)

$44

4 months 9 days ago
(17-Dec-2024)

0/11 (0%)

$26.18 (125.74%)

Buy

$41

$27.5 (203.70%)

$40

5 months 14 days ago
(12-Nov-2024)

0/4 (0%)

$18.57 (82.79%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VRDN (Viridian Therapeutics) average time for price targets to be met?

On average it took 108.88 days on average for the stock forecasts to be realized with a an average price target met ratio 15.15

Which analyst has the current highest performing score on VRDN (Viridian Therapeutics) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on VRDN (Viridian Therapeutics)?

Jason Butler works at JMP and has 5 price targets and 3 ratings on VRDN

Which analyst is the currently most bullish on VRDN (Viridian Therapeutics)?

Julian Harrison with highest potential upside - $47.5

Which analyst is the currently most reserved on VRDN (Viridian Therapeutics)?

Michael Higgins with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?